Phase 2 trial data published in 2023 showed participants receiving the highest retatrutide dose lost an average of approximately 24 percent of body weight over 48 weeks, which exceeded results seen with dual-agonist medications in comparable timeframes
It is important to note that the glucose-raising effect of glucagon receptor activation is largely counterbalanced by the GLP-1 and GIP components
XOSM Technology:Our propriety, patent-pending technology that boosts formula performance while protecting and nourishing the skins barrier with smart-encapsulated antioxidants ectoin, vitamin C and astaxanthin-rich micro-algae
The side effects are predominantly temporary, manageable with the right strategies, and do not outweigh the substantial benefits semaglutide offers for weight management and metabolic health
Its about ecosystems, devices, partnerships & patient ownership Big Takeaway: Dr
Weight loss comparison at maximum doses Retatrutide produces the most weight loss at maximum dose, and the gap is meaningful